IKZF1 mutation
|
B Acute Lymphoblastic Leukemia
|
IKZF1 mutation
|
B Acute Lymphoblastic Leukemia
|
inotuzumab ozogamicin Sensitive: C3 – Early Trials
|
inotuzumab ozogamicin Sensitive: C3 – Early Trials
|
IKZF1 mutation
|
ALL
|
IKZF1 mutation
|
ALL
|
blinatumomab Sensitive: C3 – Early Trials
|
blinatumomab Sensitive: C3 – Early Trials
|